Novyra Pharmachem logo

Novyra Pharmachem MD, chairman, board of directors and AGM

BSE: 519353Agricultural Food & other ProductsSmall Cap

Last close ₹8.50down ₹0.21 (2.41%)

Share price at the BSE close on 13 Oct 2026. Previous close ₹8.71.

52-week range of traded prices to 13 Oct 2026
₹6.47Low, 13 Oct 2025₹16.55High, 23 Mar 2026
Market cap
₹5.38 Cr4,706th largest listed
P/E
Lossover the last 12 months
P/B
9.1
Dividend yield
Nonein the last 12 months
ROE
−166.3%
ROCE
−906.7%
Debt to equity
0.00
Volume, BSE
100

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • D G M S & CoPeer-review certificate valid to Feb 2029
1 earlier auditor
  • DGMS & Co.Named in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.